Worldwide Stem Cell Hospitals & Research Facilities

GIOSTAR is a coalition of some of the world’s most prestigious scientific minds in the field of stem cell science, genetics, and cancer research. For close to 20 years,  GIOSTAR’s team of scientists and clinicians have been involved in the development and utilization of stem cell based clinical protocols related to stem cell transplants to treat autoimmune diseases.

The GIOSTAR team includes international leaders in the field of adult stem cell and induced pluripotent stem cell research and technology. The GIOSTAR team was the first to demonstrate the significance of stem cell use in the development of therapies for several degenerative diseases related to tissue and organs. The publications of these therapies have been thoroughly investigated and documented by many noted journals of medicine. GIOSTAR continues to lead the most advanced research in the field of stem cell science with the goal of developing new therapies for future clinical use.

GIOSTAR uses adult stem cell for its autologous and allogeneic stem cells therapy to treat patients. Their adult stem cell technology is well developed and is currently being used regularly in clinical practice. GIOSTAR’s clinicians are licensed to treat patients using autologous (their own) and allogeneic (from others) adult stem cells for certain diseases.

GIOSTAR currently has seventeen stem cell treatment facilities operating or under development around the world including the Cellebration Life Sciences, Inc. facility to be developed in Costa Rica.  In addition, Cellebration’s modern research facility to be located in San Diego, California, will be the world’s most advanced stem cell research laboratory and will be the headquarters for Cellebration and GIOSTAR’s global research efforts.